1. International Agency for Research on Cancer (2020) Prostate Source: Globocan 2020 Number of new cases in 2020, both sexes, all ages. [cited 2022 Dec 4];1–2. https://gco.iarc.fr/today
2. Mottet N, Bellmunt J, Briers E, van den Bergh RCN, van Casteren NJ, Cornford P, et al. (2022) EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. Eur Assoc Urol ISBN 978–9(March):1–137. https://uroweb.org/guideline/prostate-cancer/#3
3. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol. 22(4):746–57
4. Grey AD, Chana MS, Popert R, Wolfe K, Liyanage SH, Acher PL (2015) Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting. BJU Int. 115(5):728–35
5. Vilanova JC, Comet J, Garcia-Figueiras R, Barceló J, Boada M (2010) Utilidad de la resonancia magnética en el cáncer de próstata. Radiologia 52(6):513–524